Moraviec joins Michael Steadman, president of Wound Therapeutics, and Nino Pionati, president of Ostomy Care, who recently assumed regional responsibility for ConvaTec USA and ConvaTec Intercontinental, respectively. A fourth business unit, Infusion Devices, is headed by John Lindskog. As president, Moraviec will join the company’s executive committee.

“Paul is a proven leader with an outstanding track record of driving growth across a number of medical device specialties, making him the ideal person to leverage the newly combined product portfolio for further penetration into the acute care and home health care settings,” said David Johnson, chief executive officer (CEO), ConvaTec. “With Paul’s appointment, we now have the team in place to fully capitalize on the opportunities ahead and lead ConvaTec in achieving our goal of becoming the growth leader in each of our markets and key business areas.”

Before joining ConvaTec, Moraviec was CEO of Prosurgics Limited, a surgical robotics company. Prior to Prosurgics Limited, Moraviec held the position of vice president, international commercial operations for Abbott Laboratories Diabetes Care Division, where he was responsible for transforming the performance of the business to sales of $700 million and a strong growth and profitability profile. In addition, Moraviec has held the roles of CEO of IIT Ltd, a UK medical device start-up company and vice president, international sales and marketing for Codman, a Johnson & Johnson medical devices and diagnostics company.